RING1 and acute myeloid leukemia: PRC1 is also gaining interest in the field as a druggable target in AML and can be sorted into 2 separate subcategories: canonical PRC1 and noncanonical PRC1.86 All iterations of PRC1 contain RING1 and PCGF proteins.